Evidence map›Paper›PMID 12663768›Full record

ArticleJournal of virology2003

The extreme carboxyl terminus of v-Abl is required for lymphoid cell transformation by Abelson virus.

David Warren, Deborah S Griffin, Celine Mainville, Naomi Rosenberg

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

David WarrenDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts 02111, USA.
Deborah S Griffin
Celine Mainville
Naomi Rosenberg
Tufts University · US

Funding

ABELSON LEUKEMIA VIRUS TRANSFORMATIONR01CA024220 · NCI · TUFTS UNIVERSITY BOSTON · PI ROSENBERG, NAOMI · 1985 to 2005
$1.8M
NCI NIH HHS CA 24220NCI NIH HHS R01 CA024220
6 · The paper itself

Abstract

The v-Abl protein tyrosine kinase encoded by Abelson murine leukemia virus (Ab-MLV) induces transformation of pre-B cells in vivo and in vitro and can transform immortalized fibroblast cell lines in vitro. Although the kinase activity of the protein is required for these events, most previously studied mutants encoding truncated v-Abl proteins that lack the extreme carboxyl terminus retain high transforming capacity in NIH 3T3 cells but transform lymphocytes poorly. To understand the mechanisms responsible for poor lymphoid transformation, mutants expressing a v-Abl protein lacking portions of the COOH terminus were compared for their ability to transform pre-B cells. Although all mutants lacking sequences within the COOH terminus were compromised for lymphoid transformation, loss of amino acids in the central region of the COOH terminus, including those implicated in JAK interaction and DNA binding, decreased transformation twofold or less. In contrast, loss of the extreme COOH terminus rendered the protein unstable and led to rapid proteosome-mediated degradation, a feature that was more prominent when the protein was expressed in Ab-MLV-transformed lymphoid cells. These data indicate that the central portion of the COOH terminus is not essential for lymphoid transformation and reveal that one important function of the COOH terminus is to stabilize the v-Abl protein in lymphoid cells.

Indexed as

Cell Transformation, ViralGene Expression Regulation, Viral3T3 CellsAbelson murine leukemia virusAnimalsBase SequenceCell LineCell Line, TransformedDNA-Binding ProteinsGene DeletionHumansLymphocytesMiceMolecular Sequence DataOncogene Proteins v-ablPhosphoproteinsDNA-Binding ProteinsDOK1 protein, humanDok1 protein, mouseGAP-associated protein p62Oncogene Proteins v-ablPhosphoproteinsras ProteinsRNA-Binding Proteins

Identifiers

PMID12663768
PMCPMC152141
OpenAlexW2109972492

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.